WNT5A and prostate carcinoma: In conclusion, this study shows that the WNT5A-mimicking peptide Foxy-5 significantly reduces the early metastatic spread of WNT5A-low DU145 prostate cancer cells in an in vivo orthotopic xenograft mouse model.